GP130 Cytokines in Breast Cancer and Bone

por Omokehinde, Tolu, Johnson, Rachelle W.
Publicado 2020

Re-Evaluating the Role of PTHrP in Breast Cancer

por Kane, Jeremy F., Johnson, Rachelle W.
Publicado 2023

Enrichment and detection of bone disseminated tumor cells in models of low tumor burden

por Sowder, Miranda E., Johnson, Rachelle W.
Publicado 2018

PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells

por Clements, Miranda E., Johnson, Rachelle W.
Publicado 2019

From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression

por Edwards, Courtney M., Johnson, Rachelle W.
Publicado 2021

Current Challenges for Early Career Researchers in Academic Research Careers: COVID‐19 and Beyond

por Johnson, Rachelle W., Weivoda, Megan M.
Publicado 2021

Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms

por Joseph, Gwenyth J., Johnson, Douglas B., Johnson, Rachelle W.
Publicado 2023

Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy

por Clements, Miranda E, Holtslander, Lauren, Johnson, Joshua R, Johnson, Rachelle W
Publicado 2023

Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction

por Danilin, Sabrina, Merkel, Alyssa R., Johnson, Joshua R., Johnson, Rachelle W., Edwards, James R., Sterling, Julie A.
Publicado 2012

Sex‐Specific Differences in G(s)α‐Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone

por Swami, Srilatha, Johnson, Joshua, Vecchi, Lawrence A, Kim, Matthew J, Lanske, Beate, Johnson, Rachelle W, Wu, Joy Y
Publicado 2022

Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent Manner

por Johnson, Rachelle W., Sun, Yao, Ho, Patricia W. M., Chan, Audrey S. M., Johnson, Jasmine A., Pavlos, Nathan J., Sims, Natalie A., Martin, T. John
Publicado 2018

Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner

por Todd, Vera M., Vecchi, Lawrence A., Clements, Miranda E., Snow, Katherine P., Ontko, Cayla D., Himmel, Lauren, Pinelli, Christopher, Rafat, Marjan, Johnson, Rachelle W.
Publicado 2021

HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer

por Clements, Miranda E., Holtslander, Lauren, Edwards, Courtney, Todd, Vera, Dooyema, Samuel D.R., Bullock, Kennady, Bergdorf, Kensey, Zahnow, Cynthia A., Connolly, Roisin M., Johnson, Rachelle W.
Publicado 2021

EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

por Vaught, David B, Merkel, Alyssa R, Lynch, Conor C, Edwards, James, Tantawy, Mohammed Noor, Hilliard, Timothy, Wang, Shan, Peterson, Todd, Johnson, Rachelle W, Sterling, Julie A, Brantley‐Sieders, Dana
Publicado 2021

Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow

por Johnson, Rachelle W., Finger, Elizabeth C., Olcina, Monica M., Vilalta, Marta, Aguilera, Todd, Miao, Yu, Merkel, Alyssa R., Johnson, Joshua R., Sterling, Julie A., Wu, Joy Y., Giaccia, Amato J.
Publicado 2016

Bone corticalization requires local SOCS3 activity and is promoted by androgen action via interleukin-6

por Cho, Dae-Chul, Brennan, Holly J., Johnson, Rachelle W., Poulton, Ingrid J., Gooi, Jonathan H., Tonkin, Brett A., McGregor, Narelle E., Walker, Emma C., Handelsman, David J., Martin, T. J., Sims, Natalie A.
Publicado 2017